Guillain-Barré syndrome (GBS) is a well-established complication of infectious disease. So it is not surprising that several cases have been described during the actual SARS-CoV-2 infection pandemic. Most of the descriptions are patients suffering a severe GBS in the setting of a severe SARS-CoV-2 infection. We described five patients with mild forms of COVID-19. After 2-4 weeks, these patients develop mild neurological symptoms. The clinical and neurophysiological studies supported a diagnosis of an acute polyneuropathy. Symptoms resolved without specific treatment and primary care physicians managed all patients outpatiently. Mild SARS-CoV-2 infection could associate mild neurological complications too. So patients complaining about mild neurological symptoms, a SARS-CoV-2 infection may be excluded.
Supplementary information: The online version contains supplementary material available at 10.1007/s42399-021-00855-x.
Keywords: Acute polyneuropathy; COVID-19; Guillain-Barré syndrome; SARS-CoV-2.
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021.